SCHEMBL29489796

SCHEMBL29489796

[Ir+3].c1ccc(-c2nccc3ccccc23)cc1.c1ccc(-c2nccc3ccccc23)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.64
NPC1 O15118 3/20 0.64
RAB9A P51151 3/20 0.64
MAPT P10636 3/20 0.64
L3MBTL1 Q9Y468 2/20 0.64
KMT2A Q03164 2/20 0.64
GLA P06280 1/20 0.64
NPSR1 Q6W5P4 1/20 0.64
GPR55 Q9Y2T6 1/20 0.63
ALDH1A1 P00352 3/20 0.54
MAPK1 P28482 2/20 0.54
CYP3A4 P08684 2/20 0.54
CYP2C19 P33261 2/20 0.54
HPGD P15428 2/20 0.54
HSD17B10 Q99714 2/20 0.54
CYP1A2 P05177 1/20 0.54
CASP1 P29466 1/20 0.54
CASP7 P55210 1/20 0.54
ATM Q13315 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30090880 1.00 KDM4E (0.64) KDM4ENPC1RAB9AMAPTL3MBTL1
SCHEMBL29400645 1.00 KDM4E (0.64) KDM4ENPC1RAB9AMAPTL3MBTL1
SCHEMBL29398625 0.98 KDM4E (0.66) KDM4ENPC1RAB9AMAPTL3MBTL1
SCHEMBL50715 0.98 KDM4E (0.66) KDM4ENPC1RAB9AMAPTL3MBTL1
Hydrochloric Acid SCHEMBL3320794 0.96 KDM4E (0.64) KDM4ENPC1RAB9AMAPTL3MBTL1
SCHEMBL347181 0.96 KDM4E (0.64) KDM4ENPC1RAB9AMAPTL3MBTL1
SCHEMBL31275980 0.96 KDM4E (0.69) KDM4ENPC1RAB9AMAPTL3MBTL1
SCHEMBL30278644 0.96 KDM4E (0.64) KDM4ENPC1RAB9AMAPTL3MBTL1
SCHEMBL1686110 0.96 KDM4E (0.64) KDM4ENPC1RAB9AMAPTL3MBTL1
SCHEMBL30464099 0.96 KDM4E (0.64) KDM4ENPC1RAB9AMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12538704-B2 4H-imidazo[1,2-a]imidazoles for electronic applications UDC IRELAND LIMITED (IE) 2026-01-27 US disclosed
US-12376487-B2 Organic light emitting device LG DISPLAY CO., LTD. (KR) 2025-07-29 US disclosed
CN-119586362-A Display panel and display device 京东方科技集团股份有限公司 2025-03-07 CN disclosed
CN-111377895-B Heterocyclic compound, composition comprising heterocyclic compound, and organic light-emitting device comprising heterocyclic compound 三星电子株式会社 2024-10-29 CN disclosed
US-20240334814-A1 MIXED POWDER, MIXTURE, AND METHOD FOR FABRICATING ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-10-03 US disclosed
CN-111377847-B Heterocyclic compound, composition comprising same, and organic light-emitting device comprising same 三星电子株式会社 2024-07-16 CN disclosed
US-11744152-B2 Benzimidazo[1,2-a]benzimidazole derivatives for electronic applications UDC IRELAND LIMITED (IE) 2023-08-29 US disclosed
CN-109305950-B Light absorber and organic electroluminescent device including the same 三星显示有限公司 2023-08-22 CN disclosed
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 US disclosed
WO-2023063163-A1 MIXED POWDER FOR ORGANIC ELECTROLUMINESCENT ELEMENT, PRODUCTION METHOD THEREFOR, METHOD FOR MANUFACTURING ORGANIC ELECTROLUMINESCENT ELEMENT USING SAID MIXED POWDER, METHOD FOR SELECTING COMPOUND IN SAID MIXED POWDER, AND COMPOSITION FOR VACUUM DEPOSITION 出光興産株式会社 2023-04-20 WO disclosed
WO-2022244864-A1 MIXED POWDER, VAPOR DEPOSITION METHOD FOR ORGANIC COMPOUND, METHOD FOR PRODUCING ORGANIC ELECTROLUMINESCENT ELEMENT, METHOD FOR SELECTING ORGANIC COMPOUND, AND VAPOR DEPOSITION METHOD 出光興産株式会社 2022-11-24 WO disclosed
US-11505561-B2 Organic light emitting device and materials for use in same IDEMITSU KOSAN CO., LTD. (JP) 2022-11-22 US disclosed
US-11450812-B2 4H-imidazo[1,2-a]imidazoles for electronic applications UDC IRELAND LIMITED (IE) 2022-09-20 US disclosed
US-11411182-B1 Mixed powder for organic electroluminescence device and method of producing the same, method of fabricating organic electroluminescence device using the mixed powder, method of selecting compounds for the mixed powder, and composition for vacuum vapor deposition IDEMITSU KOSAN CO., LTD. (JP) 2022-08-09 US disclosed
WO-2022149757-A1 NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 주식회사 센텀머티리얼즈 2022-07-14 WO disclosed
WO-2022145806-A1 NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 주식회사 센텀머티리얼즈 2022-07-07 WO disclosed
WO-2022131669-A1 NOVEL SPIROFLUORENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME 주식회사 센텀머티리얼즈 2022-06-23 WO disclosed
EP-3356369-B1 BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE CARRYING TRIAZINE GROUPS FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO (JP) 2022-05-04 EP disclosed
US-11279709-B2 Specifically substituted aza-dibenzofurans and aza-dibenzothiophenes for organic electronic devices IDEMITSU KOSAN CO., LTD. (JP) 2022-03-22 US disclosed
EP-3640252-B1 4H-IMIDAZO[1,2-A]IMIDAZOLES FOR ELECTRONIC APPLICATIONS UDC IRELAND LTD (IE) 2022-03-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11450812-B2 4H-imidazo[1,2-a]imidazoles for electronic applications PAH, NISCH, KCNH1 KDM4E 1128/4885NPC1 3851/4885RAB9A 447/4885
US-12538704-B2 4H-imidazo[1,2-a]imidazoles for electronic applications RIF1, NR2E1, NR3C1 KDM4E 2068/4885NPC1 3180/4885RAB9A 925/4885
US-11279709-B2 Specifically substituted aza-dibenzofurans and aza-dibenzothiophenes for organic electronic devices CDY1; CDY1B, CDYL, CBX8 KDM4E 215/4885NPC1 3768/4885RAB9A 725/4885
US-20240334814-A1 MIXED POWDER, MIXTURE, AND METHOD FOR FABRICATING ORGANIC ELECTROLUMINESCENCE DEVICE EML4, ORC3, ZRANB2 KDM4E 1805/4885NPC1 1535/4885RAB9A 2200/4885
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 KDM4E 962/4885NPC1 2663/4885RAB9A 2910/4885
US-11505561-B2 Organic light emitting device and materials for use in same CYBA, CLTB, XPO6 KDM4E 3801/4885NPC1 2277/4885RAB9A 1260/4885
US-11744152-B2 Benzimidazo[1,2-a]benzimidazole derivatives for electronic applications PAICS, EIF4A1, ECI1 KDM4E 2260/4885NPC1 4384/4885RAB9A 1588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.